5 documents found, page 1 of 1
A comprehensive systematic review of leishmaniasis in patients undergoing drug-...
Kurizky, Patricia Shu; Marianelli, Fernanda Ferraço; Cesetti, Mariana Vicente; Damiani, Giovanni; Sampaio, Raimunda Nonata RibeiroImmunosuppression is an important risk factor for leishmaniasis. We assessed the clinical profile, geographic distribution and prevalence of leishmaniasis in patients undergoing immunosuppressive therapy for dermatological, rheumatological or gastroenterological autoimmune diseases. We identified relevant studies in PubMed, EMBASE, Scopus, Web of Science and LILACS on July 3rd, 2018. We included articles that r...
Estudo piloto randomizado e controlado, usando a Associação de Miltefosina e Pe...
Martins, Sofia SalesTese (Doutorado)—Universidade de Brasília, Faculdade de Ciências da Saúde, Programa de Pós-Graduação em Ciências Da Saúde, 2021.; A leishmaniose tegumentar americana (LTA) é endêmica no Brasil com grande impacto na saúde pública do país. Os tratamentos atualmente preconizados apresentam elevada frequência de efeitos adversos (EA) e crescentes taxas de falha terapêutica com resistência parasitária. Objetivo: Ava...
A randomized, open-label clinical trial comparing the long-term effects of milt...
Sampaio, Raimunda Nonata Ribeiro; Silva, Juliana Saboia Fontenele e; Paula, Carmen Dea Ribeiro de; Porto, CláudiaINTRODUCTION: The treatment of mucosal leishmaniasis (ML) is difficult due to the toxicity and route of administration of standard drugs. Miltefosine is an oral agent used for leishmaniasis treatment; however, no data exist regarding its use for ML in Brazil. In this study, we aimed to evaluate the efficacy of miltefosine for ML treatment compared to that of pentavalent antimonial in a pilot study. METHODS: We ...
A comprehensive systematic review of leishmaniasis in patients undergoing drug-...
Kurizky, Patrícia Shu; Marianelli, Fernanda Ferraço; Cesetti, Mariana Vicente; Damiani, Giovanni; Sampaio, Raimunda Nonata RibeiroImmunosuppression is an important risk factor for leishmaniasis. We assessed the clinical profile, geographic distribution and prevalence of leishmaniasis in patients undergoing immunosuppressive therapy for dermatological, rheumatological or gastroenterological autoimmune diseases. We identified relevant studies in PubMed, EMBASE, Scopus, Web of Science and LILACS on July 3rd, 2018. We included articles that r...
American cutaneous leishmaniasis triggered by electrocoagulation
Martins, Sofia Sales; Santos, Adriana de Oliveira; Lima, Beatriz Dolabela; Gomes, Ciro Martins; Sampaio, Raimunda Nonata RibeiroCutaneous leishmaniasis is usually transmitted by infected phlebotomine sand fly bites that initiate local cutaneous lesions. Few reports in the literature describe other modes of transmission. We report a case of a previously healthy 59-year-old woman who underwent electrocoagulation to remove seborrheic keratosis confirmed by dermatoscopy. Three months later, a skin fragment tested positive for Leishmania cul...